Weekly intravenous bortezomib is effective and well tolerated in relapsed/refractory myeloma
Moore, Sally, Atwal, Sangeeta, Sachchithanantham, Sajitha, Streetly, Matthew, Khan, Iftekhar, Percy, Laura, Narat, Santosh, D'Sa, Shirley, Rabin, Neil, Johnston, Rosalynd, Schey, Steve, Yong, KweeVolume:
90
Language:
english
Journal:
European Journal of Haematology
DOI:
10.1111/ejh.12070
Date:
May, 2013
File:
PDF, 107 KB
english, 2013